nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—gallbladder cancer	0.0982	0.0982	CbGpPWpGaD
Irbesartan—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—gallbladder cancer	0.0474	0.0474	CbGpPWpGaD
Irbesartan—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—gallbladder cancer	0.038	0.038	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—KEAP1—gallbladder cancer	0.0207	0.0207	CbGpPWpGaD
Irbesartan—JUN—Estrogen signaling pathway—BCL2—gallbladder cancer	0.0195	0.0195	CbGpPWpGaD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—ERBB3—gallbladder cancer	0.019	0.019	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—ERBB4—gallbladder cancer	0.0176	0.0176	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—BCL2—gallbladder cancer	0.0158	0.0158	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—ERBB3—gallbladder cancer	0.0152	0.0152	CbGpPWpGaD
Irbesartan—AGTR1—Arf6 signaling events—EGFR—gallbladder cancer	0.0125	0.0125	CbGpPWpGaD
Irbesartan—JUN—IL-5 Signaling Pathway—BCL2—gallbladder cancer	0.0125	0.0125	CbGpPWpGaD
Irbesartan—JUN—FAS pathway and Stress induction of HSP regulation—BCL2—gallbladder cancer	0.012	0.012	CbGpPWpGaD
Irbesartan—JUN—IL-2 Signaling Pathway—BCL2—gallbladder cancer	0.012	0.012	CbGpPWpGaD
Irbesartan—JUN—MAPK Cascade—NRAS—gallbladder cancer	0.012	0.012	CbGpPWpGaD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—ERBB2—gallbladder cancer	0.0119	0.0119	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—BCL2—gallbladder cancer	0.0106	0.0106	CbGpPWpGaD
Irbesartan—JUN—MAPK Cascade—KRAS—gallbladder cancer	0.0103	0.0103	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—BCL2—gallbladder cancer	0.00983	0.00983	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—ERBB2—gallbladder cancer	0.00955	0.00955	CbGpPWpGaD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00933	0.00933	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—BCL2—gallbladder cancer	0.00916	0.00916	CbGpPWpGaD
Irbesartan—JUN—Pre-NOTCH Transcription and Translation—TP53—gallbladder cancer	0.00914	0.00914	CbGpPWpGaD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—NRAS—gallbladder cancer	0.00906	0.00906	CbGpPWpGaD
Irbesartan—JUN—MAPK Cascade—HRAS—gallbladder cancer	0.00874	0.00874	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—NRAS—gallbladder cancer	0.00872	0.00872	CbGpPWpGaD
Irbesartan—EDNRA—Endothelins—HRAS—gallbladder cancer	0.00802	0.00802	CbGpPWpGaD
Irbesartan—JUN—IL-5 Signaling Pathway—KRAS—gallbladder cancer	0.00795	0.00795	CbGpPWpGaD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—TP53—gallbladder cancer	0.00787	0.00787	CbGpPWpGaD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—KRAS—gallbladder cancer	0.0078	0.0078	CbGpPWpGaD
Irbesartan—JUN—Signaling of Hepatocyte Growth Factor Receptor—HRAS—gallbladder cancer	0.0077	0.0077	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00753	0.00753	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—KRAS—gallbladder cancer	0.00751	0.00751	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—NRAS—gallbladder cancer	0.00727	0.00727	CbGpPWpGaD
Irbesartan—JUN—ATM Signaling Pathway—TP53—gallbladder cancer	0.00707	0.00707	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—BCL2—gallbladder cancer	0.00691	0.00691	CbGpPWpGaD
Irbesartan—JUN—Signaling events regulated by Ret tyrosine kinase—HRAS—gallbladder cancer	0.0069	0.0069	CbGpPWpGaD
Irbesartan—JUN—PDGF Pathway—HRAS—gallbladder cancer	0.0069	0.0069	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—ERBB4—gallbladder cancer	0.00682	0.00682	CbGpPWpGaD
Irbesartan—JUN—ErbB2/ErbB3 signaling events—HRAS—gallbladder cancer	0.00663	0.00663	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—EGFR—gallbladder cancer	0.00662	0.00662	CbGpPWpGaD
Irbesartan—JUN—IL-2 Signaling Pathway—HRAS—gallbladder cancer	0.0065	0.0065	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—BCL2—gallbladder cancer	0.00648	0.00648	CbGpPWpGaD
Irbesartan—JUN—Pre-NOTCH Expression and Processing—TP53—gallbladder cancer	0.00643	0.00643	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—HRAS—gallbladder cancer	0.00638	0.00638	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—KRAS—gallbladder cancer	0.00626	0.00626	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—KRAS—gallbladder cancer	0.00626	0.00626	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.00619	0.00619	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	0.00589	0.00589	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—EGFR—gallbladder cancer	0.00578	0.00578	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—BCL2—gallbladder cancer	0.00578	0.00578	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—HRAS—gallbladder cancer	0.00575	0.00575	CbGpPWpGaD
Irbesartan—JUN—Copper homeostasis—TP53—gallbladder cancer	0.00573	0.00573	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—EGFR—gallbladder cancer	0.00564	0.00564	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—BCL2—gallbladder cancer	0.00561	0.00561	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—TP53—gallbladder cancer	0.00556	0.00556	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—EGFR—gallbladder cancer	0.00551	0.00551	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—ERBB2—gallbladder cancer	0.00545	0.00545	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00533	0.00533	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—HRAS—gallbladder cancer	0.00532	0.00532	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—HRAS—gallbladder cancer	0.00532	0.00532	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—HRAS—gallbladder cancer	0.00532	0.00532	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—HRAS—gallbladder cancer	0.00482	0.00482	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—NRAS—gallbladder cancer	0.00475	0.00475	CbGpPWpGaD
Irbesartan—JUN—Endothelins—HRAS—gallbladder cancer	0.0047	0.0047	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—HRAS—gallbladder cancer	0.00464	0.00464	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—BCL2—gallbladder cancer	0.00459	0.00459	CbGpPWpGaD
Irbesartan—JUN—TSH signaling pathway—HRAS—gallbladder cancer	0.00453	0.00453	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00453	0.00453	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TP53—gallbladder cancer	0.00452	0.00452	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—HRAS—gallbladder cancer	0.00447	0.00447	CbGpPWpGaD
Irbesartan—JUN—Androgen receptor signaling pathway—EGFR—gallbladder cancer	0.00444	0.00444	CbGpPWpGaD
Irbesartan—JUN—CDC42 signaling events—HRAS—gallbladder cancer	0.00432	0.00432	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.00432	0.00432	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.00427	0.00427	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—NRAS—gallbladder cancer	0.00414	0.00414	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.0041	0.0041	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00408	0.00408	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00398	0.00398	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.00397	0.00397	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TP53—gallbladder cancer	0.0039	0.0039	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.00389	0.00389	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—gallbladder cancer	0.00388	0.00388	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.00374	0.00374	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.00371	0.00371	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.0037	0.0037	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.00367	0.00367	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—gallbladder cancer	0.00366	0.00366	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—BCL2—gallbladder cancer	0.00359	0.00359	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00358	0.00358	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—KRAS—gallbladder cancer	0.00357	0.00357	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—HRAS—gallbladder cancer	0.00353	0.00353	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.00353	0.00353	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—ERBB2—gallbladder cancer	0.00349	0.00349	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00348	0.00348	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00347	0.00347	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—gallbladder cancer	0.00334	0.00334	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	0.00333	0.00333	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	0.00327	0.00327	CbGpPWpGaD
Irbesartan—JUN—Immune System—KEAP1—gallbladder cancer	0.00325	0.00325	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.00322	0.00322	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.0032	0.0032	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—gallbladder cancer	0.00317	0.00317	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—gallbladder cancer	0.00317	0.00317	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	0.00312	0.00312	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.00312	0.00312	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—EGFR—gallbladder cancer	0.00309	0.00309	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—HRAS—gallbladder cancer	0.00303	0.00303	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.003	0.003	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—gallbladder cancer	0.00295	0.00295	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.00293	0.00293	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.00293	0.00293	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.00291	0.00291	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.00281	0.00281	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.00277	0.00277	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00275	0.00275	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.00275	0.00275	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—gallbladder cancer	0.00272	0.00272	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.00272	0.00272	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.00267	0.00267	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ERBB4—gallbladder cancer	0.00265	0.00265	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.0026	0.0026	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—gallbladder cancer	0.00259	0.00259	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00259	0.00259	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.00256	0.00256	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.00252	0.00252	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.00244	0.00244	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—HRAS—gallbladder cancer	0.00243	0.00243	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—EGFR—gallbladder cancer	0.00242	0.00242	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.00242	0.00242	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00241	0.00241	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00236	0.00236	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00236	0.00236	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.00236	0.00236	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ERBB3—gallbladder cancer	0.00229	0.00229	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00228	0.00228	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00224	0.00224	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00223	0.00223	CbGpPWpGaD
Irbesartan—JUN—Insulin Signaling—HRAS—gallbladder cancer	0.00223	0.00223	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.00221	0.00221	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—gallbladder cancer	0.00207	0.00207	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.00206	0.00206	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00202	0.00202	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—HRAS—gallbladder cancer	0.00194	0.00194	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—gallbladder cancer	0.00194	0.00194	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.0019	0.0019	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ERBB4—gallbladder cancer	0.0017	0.0017	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—gallbladder cancer	0.00156	0.00156	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB4—gallbladder cancer	0.00154	0.00154	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—BCL2—gallbladder cancer	0.00148	0.00148	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ERBB3—gallbladder cancer	0.00147	0.00147	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ERBB2—gallbladder cancer	0.00144	0.00144	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB4—gallbladder cancer	0.00134	0.00134	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB3—gallbladder cancer	0.00133	0.00133	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—NRAS—gallbladder cancer	0.00119	0.00119	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB3—gallbladder cancer	0.00115	0.00115	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NRAS—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—EGFR—gallbladder cancer	0.00108	0.00108	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—KRAS—gallbladder cancer	0.00102	0.00102	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB4—gallbladder cancer	0.000997	0.000997	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EGFR—gallbladder cancer	0.000995	0.000995	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—KRAS—gallbladder cancer	0.00094	0.00094	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—NRAS—gallbladder cancer	0.000932	0.000932	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ERBB2—gallbladder cancer	0.000922	0.000922	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HRAS—gallbladder cancer	0.000869	0.000869	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB3—gallbladder cancer	0.000862	0.000862	CbGpPWpGaD
Irbesartan—JUN—Immune System—BCL2—gallbladder cancer	0.000861	0.000861	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EGFR—gallbladder cancer	0.000849	0.000849	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB2—gallbladder cancer	0.000836	0.000836	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—KRAS—gallbladder cancer	0.000802	0.000802	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HRAS—gallbladder cancer	0.000799	0.000799	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB2—gallbladder cancer	0.000724	0.000724	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NRAS—gallbladder cancer	0.000702	0.000702	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HRAS—gallbladder cancer	0.000682	0.000682	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EGFR—gallbladder cancer	0.000639	0.000639	CbGpPWpGaD
Irbesartan—JUN—Immune System—NRAS—gallbladder cancer	0.000636	0.000636	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KRAS—gallbladder cancer	0.000604	0.000604	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGFR—gallbladder cancer	0.00058	0.00058	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NRAS—gallbladder cancer	0.000551	0.000551	CbGpPWpGaD
Irbesartan—JUN—Immune System—KRAS—gallbladder cancer	0.000548	0.000548	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB2—gallbladder cancer	0.000541	0.000541	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—gallbladder cancer	0.000537	0.000537	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HRAS—gallbladder cancer	0.000513	0.000513	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGFR—gallbladder cancer	0.000502	0.000502	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KRAS—gallbladder cancer	0.000474	0.000474	CbGpPWpGaD
Irbesartan—JUN—Immune System—HRAS—gallbladder cancer	0.000465	0.000465	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—gallbladder cancer	0.000421	0.000421	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NRAS—gallbladder cancer	0.000411	0.000411	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HRAS—gallbladder cancer	0.000403	0.000403	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGFR—gallbladder cancer	0.000375	0.000375	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KRAS—gallbladder cancer	0.000354	0.000354	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—gallbladder cancer	0.000315	0.000315	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HRAS—gallbladder cancer	0.000301	0.000301	CbGpPWpGaD
